These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 3325744

  • 1. Cytosolic potentiation of the rat hepatic microsome mediated mutagenicity of benzidine.
    Smith JN, Ioannides C.
    Mutagenesis; 1987 May; 2(3):205-9. PubMed ID: 3325744
    [Abstract] [Full Text] [Related]

  • 2. Comparative activation of 3,3'-dichlorobenzidine and related benzidines to mutagens in the Salmonella typhimurium assay by hepatic S9 and microsomes from rats pretreated with different inducers of cytochrome P-450.
    Iba MM.
    Mutat Res; 1987 Oct; 182(5):231-41. PubMed ID: 3309638
    [Abstract] [Full Text] [Related]

  • 3. Induction of the hepatic mixed-function oxidases by Aroclor 1254 in the hamster: comparison of Aroclor-induced rat and hamster preparations in the activation of pre-carcinogens in the Ames test.
    Hyde R, Smith JN, Ioannides C.
    Mutagenesis; 1987 Nov; 2(6):477-82. PubMed ID: 3127658
    [Abstract] [Full Text] [Related]

  • 4. Benzidine activation in the Ames test: roles of hepatic N-acetyltransferase and other cytosolic and microsomal factors.
    Light HC, Hubert JJ, Josephy PD, Mattano SS, Weber WW.
    Carcinogenesis; 1987 Jan; 8(1):139-43. PubMed ID: 3542272
    [Abstract] [Full Text] [Related]

  • 5. Cytosolic activation of 2-aminoanthracene: implications in its use as diagnostic mutagen in the Ames test.
    Ayrton AD, Neville S, Ioannides C.
    Mutat Res; 1992 Jan; 265(1):1-8. PubMed ID: 1370238
    [Abstract] [Full Text] [Related]

  • 6. Metabolic activation of 2-amino-3-methylimidazo(4,5-f)quinoline by hepatic preparations--contribution of the cytosolic fraction and its significance to strain differences.
    Abu-Shakra A, Ioannides C, Walker R.
    Mutagenesis; 1986 Sep; 1(5):367-70. PubMed ID: 3331675
    [Abstract] [Full Text] [Related]

  • 7. Mutagenicity of benzidine and 4-aminobiphenyl after metabolic activation with isolated hepatocytes and liver 9000 X g supernatant from rat, hamster and guinea pig.
    Neis JM, van Gemert PJ, Roelofs HM, Bos RP, Henderson PT.
    Mutat Res; 1984 Oct; 129(1):13-8. PubMed ID: 6387464
    [Abstract] [Full Text] [Related]

  • 8. Arylamine activation following chronic ethanol ingestion by rats: studies on the liver S9, microsomal and cytosolic fractions and comparison with Aroclor 1254 pretreatment.
    Traynor CA, Shane BS, Hajos AK, Winston GW.
    Mutat Res; 1991 Mar; 247(1):153-66. PubMed ID: 2002800
    [Abstract] [Full Text] [Related]

  • 9. Influence of microsomal and cytosolic fractions from rat, mouse, and hamster liver on the mutagenicity of dimethylnitrosamine in the Salmonella plate incorporation assay.
    Prival MJ, Mitchell VD.
    Cancer Res; 1981 Nov; 41(11 Pt 1):4361-7. PubMed ID: 7030474
    [Abstract] [Full Text] [Related]

  • 10. Activation of aromatic amines to mutagens by various animal species including man.
    Phillipson CE, Ioannides C.
    Mutat Res; 1983 Dec; 124(3-4):325-36. PubMed ID: 6361543
    [Abstract] [Full Text] [Related]

  • 11. Prostaglandin H synthase-dependent mutagenic activation of benzidine in a Salmonella typhimurium Ames tester strain possessing elevated N-acetyltransferase levels.
    Josephy PD, Chiu AL, Eling TE.
    Cancer Res; 1989 Feb 15; 49(4):853-6. PubMed ID: 2492207
    [Abstract] [Full Text] [Related]

  • 12. The effect of acetyl-CoA supplementation on the mutagenicity of benzidines in the Ames assay.
    Kennelly JC, Stanton CA, Martin CN.
    Mutat Res; 1984 Jul 15; 137(1):39-45. PubMed ID: 6379437
    [Abstract] [Full Text] [Related]

  • 13. Bioactivation of 6-aminochrysene by animal and human hepatic preparations: contributions of microsomal and cytosolic enzyme systems.
    Marczylo T, Ioannides C.
    Mutagenesis; 1994 May 15; 9(3):233-9. PubMed ID: 7934963
    [Abstract] [Full Text] [Related]

  • 14. Difference in liver homogenates from Donryu, Fischer, Sprague-Dawley and Wistar strains of rat in the drug-metabolizing enzyme assay and the Salmonella/hepatic S9 activation test.
    Yoshikawa K, Nohmi T, Miyata R, Ishidate M, Ozawa N, Isobe M, Watabe T, Kada T, Kawachi T.
    Mutat Res; 1982 Oct 15; 96(2-3):167-86. PubMed ID: 6755239
    [Abstract] [Full Text] [Related]

  • 15. Bioactivation of N-nitrosopiperidine to mutagens: role of hepatic cytochrome P-450 proteins and contribution of cytosolic fraction.
    Ayrton AD, Smith JN, Ioannides C.
    Carcinogenesis; 1987 Nov 15; 8(11):1691-5. PubMed ID: 3664960
    [Abstract] [Full Text] [Related]

  • 16. A cytosolic oxygenase activity involved in the bioactivation of 2-aminofluorene.
    Leist M, Ayrton AD, Ioannides C.
    Toxicology; 1992 Nov 15; 71(1-2):7-20. PubMed ID: 1729770
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Structure-mutagenicity relationships of benzidine analogues.
    Messerly EA, Fekete JE, Wade DR, Sinsheimer JE.
    Environ Mol Mutagen; 1987 Nov 15; 10(3):263-74. PubMed ID: 3315653
    [Abstract] [Full Text] [Related]

  • 19. The Salmonella/mammalian microsome mutagenicity test: comparison of human and rat livers as activating systems.
    Beaune P, Lemestré-Cornet R, Kremers P, Albert A, Gielen J.
    Mutat Res; 1985 Jun 15; 156(3):139-46. PubMed ID: 3889631
    [Abstract] [Full Text] [Related]

  • 20. Comparative mutagenicity tests in the Salmonella/microsome assay with rat and woodchuck S9 preparations.
    Rashid KA, Babish JG, Johnson BE, Mumma RO.
    Toxicology; 1985 Aug 15; 36(2-3):139-46. PubMed ID: 3931301
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.